The Intelligence Revolution Webinar: Exploring the Past, Present, and Future of AI
April 2023
Stuart Blair, CAIA, Director of Research, Canterbury Consulting and Kellan Carter, General Partner, FUSE Ventures discussed the advancements, ethics, and impact of Artificial Intelligence.
The Difference Between Dementia and Alzheimer’s Disease
March 2023
Dean Frank LaFerla of the School of Biological Sciences at the University of California, Irvine, compares the key differences between the various forms of dementia including the most common, Alzheimer’s Disease, this year at Canterbury Consulting’s annual client education event.
Risk factors For Alzheimer's Disease
January 2023
At the 2023 Investment Forum, Dean Frank LaFerla lays out the key risk factors of Alzheimer’s with the most significant risk factor being age. One out of every 20 people over the age of 65 will be afflicted by Alzheimer’s and that number doubles every 5 years thereafter. Lifestyle factors including high cholesterol as well as diabetes have a greater risk of developing Alzheimer’s Disease.
Healthy Practices to Slow the Course of Alzheimer's Disease
January 2023
UCI’s Dean Frank LaFerla discusses the benefits and connection of a healthy body and healthy mind. Individuals that exercise regularly, eat healthy, lifelong learners, and socialize have a lower rate of development or slow the rate of decline.
Challenges in Diagnosis of Alzheimer’s Disease
January 2023
2023 Investment Forum — Dean Frank LaFerla explains the complexity behind Alzheimer’s disease and the challenges of accurately diagnosing the disease.
Key Drug Developments to Treat of Alzheimer’s Disease
January 2023
Dean Frank LaFerla reviews the development of drugs to treat Alzheimer’s including symptomatic treatments, drugs designed to affect one’s cognitive ability but not alter the disease course. Over the last month, there is a new drug that is an antibody treatment to alter the disease course, slowing down rate of cognitive decline by 25-27%.